Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-05-17 @ 12:18 PM
Study NCT ID:
NCT02556333
Status:
TERMINATED
Last Update Posted:
2017-11-14
First Post:
2015-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Emtricitabine/Tenofovir Alafenamide as Salvage ART
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
150201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None